Supernus Pharmaceuticals
SUPN
#4394
Rank
โ‚ฌ1.58 B
Marketcap
28,34ย โ‚ฌ
Share price
2.78%
Change (1 day)
3.46%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): โ‚ฌ90.34 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.66 Billion. , an increase over its 2023 earnings that were of โ‚ฌ4.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ86.08 M1787.92%
2023 โ‚ฌ4.55 M-92.36%
2022 โ‚ฌ59.64 M-29.8%
2021 โ‚ฌ84.96 M-49.79%
2020 โ‚ฌ0.16 B12.99%
2019 โ‚ฌ0.14 B7.58%
2018 โ‚ฌ0.13 B54.9%
2017 โ‚ฌ89.88 M84.25%
2016 โ‚ฌ48.78 M202.27%
2015 โ‚ฌ16.13 M-462.04%
2014 -โ‚ฌ4.46 Million-94%
2013 -โ‚ฌ74.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.19 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.39 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.15 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.38 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.16 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.34 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA